Procurement of UPADACITINIB (RINVOQ) HOMECARE 15 mg Modified-Release Tablets

GoodsAward procedure without prior publication of a call for competition

Awarded value£250,000published contract · exc. VAT

Awarded 30 Sept 2022no call for competition

Awarded to Sciensus Pharma Services Ltd (HAH)

What is being bought

Published requirement description

Procurement of UPADACITINIB (RINVOQ) HOMECARE 15 mg Modified-Release Tablets Patent Protected Medicines

CPV: Medical equipments, pharmaceuticals and personal care products

single lot · no lot value published

Lot #1UPADACITINIB (RINVOQ) HOMECARE 15 mg Modified-Release Tablets, Patent Protected MedicinesAwarded

Delivery: Northern Ireland · Belfast Health and Social Care Trust

From the official record

Procedure method: Award procedure without prior publication of a call for competition
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 28 Oct 2022, 16:08 BST
Last source update: 28 Oct 2022, 16:08 BST
Authority reference: DACPM2022-40
FTS notice number: 2022/S 000-030566
Classification (CPV): Medical equipments, pharmaceuticals and personal care products
Delivery area: Northern Ireland (UKN)
Official registry OCID: ocds-h6vhtk-037d68 Find a Tender

Why no open competition: The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights
Published justification: These essential medicines are required for continuity of patient care. These medicines are available only from one economic operator. BHSCT can confirm that the absence of competition is not a result of the artificial narrowing of the parameters of the procurement.

Published awards, contracts and bid statistics, not a forecast

Awards 1

Awarded value £250,0001 contract exc. VAT

Bids received 1

Contracts signed 1latest 30 Sept 2022

Awarded to	Value	Date	Status
Sciensus Pharma Services Ltd (HAH)	£250,000 †	—	Awarded

Contracts

Procurement of UPADACITINIB (RINVOQ) HOMECARE 15 mg Modified-Release Tablets · Sciensus Pharma Services Ltd (HAH)
Signed
30 Sept 2022
Value
£250,000
Status
active

Bid statistics published by the authority

Bids	SME	VCSE	Valid bid range
1bids	—	—	—

Contracting authorityCentral GovernmentBody governed by public lawHealth LISBURN ROAD, BELFAST, Northern Ireland, BT97ABContact name, email

Dispute resolution & review bodies

1 commercial party on the notice

Sciensus Pharma Services Ltd (HAH)Awarded supplier Fifth Avenue, Centrum 100, Burton on Trent, East Midlands, DE14 2WS

Official links; attachments are not copied

No document links were published on the notice.